A Randomized Control Study: Comparison of Two Iron preparations for Anemia in Pregnant Women: Ferric Carboxymaltose vs. Iron Sucrose

COMPARATIVE STUDY OF INTRAVENOUS FERRIC CARBOXY MALTOSE VERSUS INTRAVENOUS IRON SUCROSE FOR TREATMENT OF ANEMIA IN PREGNANCY - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/074985

Enrollment

100

Registered

2024-10-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O990- Anemia complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: Administration of 1gm of Ferric Carboxy maltose: Single dose Intravenous administration of 1gm of Ferric Carboxy maltose in 250ml Normal saline over 20 minutes Control Intervention1

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with mild to moderate anemia. 2.Antenatal patients with a period of gestation 16- 32 weeks of gestation. 3.Patients with Iron deficiency anemia.

Exclusion criteria

Exclusion criteria: 1.Pregnancy more than 32 weeks of gestation. 2.K/C/O thalassemia& sickle cell anemia. 3.H/O allergic reactions to iron preparations. 4. History of blood transfusion in last 3months.

Design outcomes

Primary

Measure	Time frame
To study and compare the difference in rise in hemoglobin on administration of IV ferric carboxymaltose and IV iron sucrose.Timepoint: To Compare the efficacy of IV Ferric Carboxymaltose and IV Iron Sucrose after 4 weeks of last dose	—

Secondary

Measure	Time frame
To Compare the secondary response of IV Ferric Carboxymaltose & IV Iron SucroseTimepoint: To compare secondary response to IV Ferric Carboxymaltose & IV Iron Sucrose after 30 minutes of administration	—

Countries

India

Contacts

Public ContactDR SANTOSH B NIRWANI

KARNATAKA MEDICAL COLLEGE AND RESEARCH INSTITUTE HUBBALLI

svn1974@gmail.com9343882242

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026